Source: International Congress 2015 – Monitoring and phenotyping COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Barbora Novotná (Hradec Kralove, Czech Republic), Barbora Novotna, Mohammed Abdel-Hamid, Vladimir Koblizek, Jiri Jarkovsky, Karel Hejduk, Vit Rehacek, Josef Bis, Frantisek Salajka. A liquid chromatography MS/MS metabolomics study of COPD patients. Eur Respir J 2015; 46: Suppl. 59, 3356

Member's Comments

No comment yet.

Related content which might interest you: Mass spectrometry proteomic biomarkers identify acute COPD exacerbations Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Breath analysis by ion mobility spectrometry in COPD and lung cancer patients Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Metabolic profiling detects biomarkers of protein degradation in COPD patients Source: Eur Respir J 2012; 40: 345-355 Year: 2012 Serum metabolomic analysis of mustard airway diseases by nuclear magnetic resonance spectrometry: A pilot study Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008 Economic impact of point-of-care blood gas analysis in COPD patients Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Ion mobility spectrometry in lung transplant patients Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Metabolomic fingerprinting in the identification of biomarkers in COPD patients Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Potential markers of the progression of CRF in patients with COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 SELDI-TOF biomarkers signatures for cystic fibrosis, asthma and COPD Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009